PI3K-IP1: Key Regulator of Cellular Signaling and Cell Survival

Target Name: PIK3IP1

NCBI ID: G113791

PIK3IP1

PI3K-IP1: Key Regulator of Cellular Signaling and Cell Survival

Phosphoinositide-3-kinase-interacting protein 1 (PI3K-IP1) is a protein that plays a crucial role in cellular signaling and cell survival. It is a key regulator of the PI3K/Akt signaling pathway, which is involved in various cellular processes such as cell growth, differentiation, and survival. PI3K-IP1 is a protein that is expressed in various tissues and cells in the body, including neurons, cardiac muscle cells, and cancer cells. Its function is highly conserved across species, and it has been implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Drugs that target PI3K-IP1 have the potential to be anti-cancer and/or anti-inflammatory drugs. One of the main reasons for this is that PI3K-IP1 is involved in the PI3K/Akt signaling pathway, which is a known pathway for cancer and neurodegenerative disease. Activation of this pathway can lead to the growth and survival of cancer cells and the progression of neurodegenerative diseases. Therefore, inhibiting PI3K-IP1 signaling has been shown to be a promising strategy for cancer and neurodegenerative disease treatment.

Expression and Localization

PI3K-IP1 is a transmembrane protein that is expressed in various tissues and cells in the body. It is predominantly expressed in the brain, heart, and pancreas, and it is also expressed in other tissues such as muscle and liver. PI3K-IP1 is predominantly localized to the endoplasmic reticulum (ER) and to the plasma membrane of various cell types. It is involved in the regulation of cellular signaling pathways, including the PI3K/Akt signaling pathway.

Function and Interaction

PI3K-IP1 is involved in the regulation of various cellular processes, including cell signaling, cell growth, and cell survival. It is a key regulator of the PI3K/Akt signaling pathway, which is involved in the regulation of cellular signaling pathways, including the cell cycle, cell growth, and cell survival. PI3K-IP1 plays a role in the regulation of the actin cytoskeleton, which is involved in the regulation of cell movement and the maintenance of cell shape.

In addition to its role in the PI3K/Akt signaling pathway, PI3K-IP1 is also involved in the regulation of various signaling pathways, including the TGF-β signaling pathway. TGF-β is a signaling pathway that is involved in the regulation of cell growth, differentiation, and survival. PI3K-IP1 is involved in the regulation of TGF-β signaling pathway by interacting with the transcription factor, Smad2.

Drugs that target PI3K-IP1 have the potential to be anti-cancer and/or anti-inflammatory drugs. One of the main reasons for this is that PI3K-IP1 is involved in the PI3K/Akt signaling pathway, which is a known pathway for cancer and neurodegenerative disease. Activation of this pathway can lead to the growth and survival of cancer cells and the progression of neurodegenerative diseases. Therefore, inhibiting PI3K-IP1 signaling has been shown to be a promising strategy for cancer and neurodegenerative disease treatment.

Conclusion

PI3K-IP1 is a protein that plays a crucial role in cellular signaling and cell survival. It is a key regulator of the PI3K/Akt signaling pathway, which is involved in various cellular processes such as cell growth, differentiation, and survival. PI3K-IP1 is primarily localized to the endoplasmic reticulum and plasma membrane of various cell types. Its function is highly conserved across species, and it has been implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Drugs that target PI3K-IP1 have the potential to be anti-cancer and/or anti-inflammatory drugs, as they can inhibit the PI3K/Akt signaling pathway, which is a known pathway for cancer and neurodegenerative disease.

Protein Name: Phosphoinositide-3-kinase Interacting Protein 1

Functions: Negative regulator of hepatic phosphatidylinositol 3-kinase (PI3K) activity

The "PIK3IP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIK3IP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets